Cardiovascular risk assessment in patients with antiphospholipid syndrome: a cross-sectional performance analysis of nine clinical risk prediction tools.

In the ‘arterial only’ group, SMART scored patients with plaques at risks above the established high-risk threshold and significantly higher than patients without plaques (23.2%±12.2% vs 16.5%±7.5%; p=0.033); a similar result was observed in the ‘arterial±venous’ group, though it did not reach statistical significance (p=0.078).

also in 111,027 other papers